Coy Travis Alan 4

4 · Immunocore Holdings plc · Filed Feb 19, 2026

AI-generated summary of this filing

Updated Feb 19, 2026

Immunocore (IMCR) CFO Travis Coy Receives Equity Awards

What Happened

Travis A. Coy, Chief Financial Officer of Immunocore Holdings plc (IMCR), received two equity awards on February 17, 2026: 33,353 restricted share units (RSUs) and 95,637 additional derivative awards (treated as an option-style award). Both grants were reported as acquisitions at $0.00 (i.e., compensation awards, not purchases or sales). The combined total granted was 128,990 units. The filing does not state an immediate cash value or any contemporaneous sale.

Key Details

Transaction date: February 17, 2026; Form 4 filed February 19, 2026 (appears timely).
Grant amounts and price: 33,353 RSUs @ $0.00; 95,637 derivative/option-style units @ $0.00.
Shares owned after transaction: not specified in the information provided in this summary.
Footnotes of note:
- F1: Each RSU represents a contingent right to receive one ordinary share.
- F2: RSUs vest in four equal annual installments beginning Feb 17, 2027, subject to continued service.
- F4: Option-style award vests 25% on Feb 17, 2027, then 6.25% quarterly thereafter, subject to continued service.
- F3: Ordinary shares may be represented by American Depositary Shares (each ADS = 1 ordinary share).
No 10b5-1 plan, tax-withholding sale, or late-filing flag was reported in the filings provided.

Context

These were compensation grants (derivative awards) with multi-year vesting schedules — not open-market purchases or immediate sales. RSUs convert to shares only as they vest; the option-style award vests over time, so any future share receipt depends on continued service and vesting.
Such grants are routine executive compensation; they do not, by themselves, indicate a near-term buy or sell decision.

Form 4

Period: 2026-02-17

Chief Financial Officer

Transactions

Award
Restricted Share Units
[F1][F2][F3]
2026-02-17+33,353→ 33,353 total
→ Ordinary Shares (33,353 underlying)
Award
Employee Share Option (Right to Buy)
[F4][F3]
2026-02-17+95,637→ 95,637 total
Exercise: $32.38Exp: 2036-02-16→ Ordinary Shares (95,637 underlying)

Footnotes (4)

[F1]Each restricted share unit ("RSU") represents a contingent right to receive one Ordinary Share.
[F2]The RSUs vest in four equal annual installments beginning February 17, 2027, subject to the Reporting Person's continuous service through each such vesting date.
[F3]Ordinary Shares may be represented by American Depositary Shares. Each American Depositary Share represents one Ordinary Share.
[F4]25% of the shares subject to the option award shall vest on February 17, 2027, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.

Signature

/s/ Lily Hepworth, Attorney-in-Fact|2026-02-19

1 file